Posted in PLoS Guest Blogger Carl Heneghan, Director of the University of Oxford’s Centre of Evidence-Based Medicine, discusses recent developments in access to clinical-trial data. The Pharmaceutical industry and drug regulators treat clinical data, submitted at the time of regulation, as confidential documents. At the same time, and to make matters worse, medical journals have…